Lexington Announces Q3 2018 Financial Results and Non-Brokered Private Placement
29 nov. 2018 23h46 HE
|
Lexington Biosciences, Inc.
VANCOUVER, British Columbia, Nov. 29, 2018 (GLOBE NEWSWIRE) -- Lexington Biosciences, Inc. (CSE: LNB) (OTCQB: LXGTF) (the “Company” or “Lexington”) announces the release of the Company’s Condensed...
Lexington Announces Non-Brokered Private Placement
27 août 2018 09h00 HE
|
Lexington Biosciences, Inc.
NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES AND DOES NOT CONSTITUTE AN OFFER OF THE SECURITIES DESCRIBED HEREIN VANCOUVER, British Columbia, Aug. 27,...
Lexington Announces First Multicenter Clinical Study Site
21 août 2018 09h00 HE
|
Lexington Biosciences, Inc.
VANCOUVER, British Columbia, Aug. 21, 2018 (GLOBE NEWSWIRE) -- Lexington Biosciences, Inc. (CSE: LNB) (OTCQB: LXGTF) (the “Company” or “Lexington”), a development-stage medical device company, is...
Lexington Biosciences Announces Results of Annual General Meeting
02 juil. 2018 19h32 HE
|
Lexington Biosciences, Inc.
VANCOUVER, British Columbia, July 02, 2018 (GLOBE NEWSWIRE) -- Lexington Biosciences, Inc. (CSE:LNB) (OTCQB:LXGTF) (the “Company” or “Lexington”), a development-stage medical device company, wishes...
Lexington Biosciences Announces Amended Terms to Previously Announced Brokered Financing
11 juin 2018 07h45 HE
|
Lexington Biosciences, Inc.
NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES AND DOES NOT CONSTITUTE AN OFFER OF THE SECURITIES DESCRIBED HEREIN VANCOUVER, British Columbia, June 11,...
Lexington Announces Brokered Private Placement
04 mai 2018 07h00 HE
|
Lexington Biosciences, Inc.
NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES AND DOES NOT CONSTITUTE AN OFFER OF THE SECURITIES DESCRIBED HEREIN VANCOUVER, B.C., May 04, 2018 (GLOBE...
Lexington Receives Approval to Commence Clinical Study
24 janv. 2018 09h00 HE
|
Lexington Biosciences, Inc.
VANCOUVER, British Columbia, Jan. 24, 2018 (GLOBE NEWSWIRE) -- Lexington Biosciences, Inc. (CSE:LNB) (OTCQB:LXGTF) (the “Company” or “Lexington”), a development-stage medical device company, is...
Lexington Completes IRB Submission in Preparation for Clinical Study
18 janv. 2018 09h00 HE
|
Lexington Biosciences, Inc.
VANCOUVER, British Columbia, Jan. 18, 2018 (GLOBE NEWSWIRE) --
Lexington Biosciences, Inc. (CSE:LNB) (OTCQB:LXGTF) (the “Company” or “Lexington”), a development-stage medical device...
Lexington Biosciences Announces Exercise of Warrants
11 janv. 2018 09h00 HE
|
Lexington Biosciences, Inc.
VANCOUVER, British Columbia, Jan. 11, 2018 (GLOBE NEWSWIRE) -- Lexington Biosciences, Inc. (CSE:LNB) (OTCQB:LXGTF) (the “Company” or “Lexington”), a development-stage medical device company, is...